| Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma HD Kim, GW Song, S Park, MK Jung, MH Kim, HJ Kang, C Yoo, K Yi, ... Gastroenterology 155 (6), 1936-1950. e17, 2018 | 244 | 2018 |
| Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer CG Kim, KH Kim, KH Pyo, CF Xin, MH Hong, BC Ahn, Y Kim, SJ Choi, ... Annals of Oncology 30 (7), 1104-1113, 2019 | 242 | 2019 |
| VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers CG Kim, M Jang, Y Kim, G Leem, KH Kim, H Lee, TS Kim, SJ Choi, ... Science immunology 4 (41), eaay0555, 2019 | 166 | 2019 |
| Innate-like cytotoxic function of bystander-activated CD8+ T cells is associated with liver injury in acute hepatitis A J Kim, DY Chang, HW Lee, H Lee, JH Kim, PS Sung, KH Kim, SH Hong, ... Immunity 48 (1), 161-173. e5, 2018 | 165 | 2018 |
| A hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis SH Choi, ZY Hong, JK Nam, HJ Lee, J Jang, RJ Yoo, YJ Lee, CY Lee, ... Clinical Cancer Research 21 (16), 3716-3726, 2015 | 156 | 2015 |
| The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors KH Kim, J Cho, BM Ku, J Koh, JM Sun, SH Lee, JS Ahn, J Cheon, YJ Min, ... Clinical Cancer Research 25 (7), 2144-2154, 2019 | 149 | 2019 |
| Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma CG Kim, C Kim, SE Yoon, KH Kim, SJ Choi, B Kang, HR Kim, SH Park, ... Journal of hepatology 74 (2), 350-359, 2021 | 148 | 2021 |
| 4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T Cells in Hepatocellular Carcinoma HD Kim, S Park, S Jeong, YJ Lee, H Lee, CG Kim, KH Kim, SM Hong, ... Hepatology 71 (3), 955-971, 2020 | 80 | 2020 |
| Senescent T cells predict the development of hyperglycemia in humans Y Lee, SR Kim, DH Han, HT Yu, YD Han, JH Kim, SH Kim, CJ Lee, ... Diabetes 68 (1), 156-162, 2019 | 62 | 2019 |
| Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy SY Chung, JS Chang, BM Lee, KH Kim, KJ Lee, J Seong Radiotherapy and Oncology 123 (3), 438-445, 2017 | 60 | 2017 |
| Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume JS Chang, HK Byun, JW Kim, KH Kim, J Lee, Y Cho, IJ Lee, KC Keum, ... Radiotherapy and Oncology 122 (1), 24-29, 2017 | 57 | 2017 |
| Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma J Park, M Kwon, KH Kim, TS Kim, SH Hong, CG Kim, SG Kang, JH Moon, ... Clinical Cancer Research 25 (8), 2549-2559, 2019 | 51 | 2019 |
| Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy YS Kim, CG Lee, KH Kim, T Kim, J Lee, Y Cho, WS Koom Radiation oncology journal 30 (4), 182, 2012 | 50 | 2012 |
| Clinical usefulness of 18F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy JS Chang, SH Choi, Y Lee, KH Kim, JY Park, SY Song, A Cho, M Yun, ... International Journal of Radiation Oncology* Biology* Physics 90 (1), 126-133, 2014 | 44 | 2014 |
| PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15 KH Kim, HK Kim, HD Kim, CG Kim, H Lee, JW Han, SJ Choi, S Jeong, ... Cellular & Molecular Immunology 18 (2), 385-397, 2021 | 43 | 2021 |
| Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment KH Kim, JY Hur, J Cho, BM Ku, J Koh, JY Koh, JM Sun, SH Lee, JS Ahn, ... Oncoimmunology 9 (1), 1722023, 2020 | 41 | 2020 |
| Dynamic changes in circulating PD-1+ CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer CG Kim, MH Hong, KH Kim, IH Seo, BC Ahn, KH Pyo, CB Synn, HI Yoon, ... European journal of cancer 143, 113-126, 2021 | 37 | 2021 |
| Hippocampus-sparing whole-brain radiotherapy and simultaneous integrated boost for multiple brain metastases from lung adenocarcinoma: early response and dosimetric evaluation KH Kim, BC Cho, CG Lee, HR Kim, YG Suh, JW Kim, C Choi, JG Baek, ... Technology in Cancer Research & Treatment 15 (1), 122-129, 2016 | 37 | 2016 |
| Therapeutic benefit of radiotherapy in huge (≥ 10 cm) unresectable hepatocellular carcinoma KH Kim, MS Kim, JS Chang, KH Han, DY Kim, J Seong Liver International 34 (5), 784-794, 2014 | 36 | 2014 |
| Radiotherapy versus cordectomy in the management of early glottic cancer SY Chung, KH Kim, KC Keum, YW Koh, SH Kim, EC Choi, CG Lee Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2018 | 35 | 2018 |
